Kory James Wentworth
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $434K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 2SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 2,500119,010 held (−2%) | $12.95 | $32K | -56.2% |
| Mar 11SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 5,089132,898 held (−4%) | $13.00 | $66K | -56.4% |
| Mar 11SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 11,388121,510 held (−9%) | $13.02 | $148K | -56.5% |
| Mar 6SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 7,988137,987 held (−5%) | $12.25 | $98K | -53.7% |
| Nov 24SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 8,910110,026 held (−7%) | $9.98 | $89K | -43.2% |
- Sell
CFO Kory James Wentworth sold $32K of TRDA at $12.95 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Kory James Wentworth sold $66K of TRDA at $13.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Kory James Wentworth sold $148K of TRDA at $13.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Kory James Wentworth sold $98K of TRDA at $12.25 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Kory James Wentworth sold $89K of TRDA at $9.98 — pre-scheduled 10b5-1 plan sale.